Followers | 98 |
Posts | 15870 |
Boards Moderated | 0 |
Alias Born | 09/13/2012 |
![](https://investorshub.advfn.com/uicon/360298.png?cb=1559326712)
Saturday, March 25, 2017 12:24:06 PM
There's no FDA approval to bring this treatment to market, it is stuck in Phase II and USRM is hoping that their RAT application will be accepted by the FDA so they can continue Phase II for MyoCell.
https://www.clinicaltrials.gov/ct2/show/NCT00526253?term=BIOHEART&rank=3
They have no on going recruitment's for Phase II MyoCell and they need hundreds of them so they can continue their clinical studies.
Any drug or treatment to get from Phase II to Phase III to Phase IV takes years if ever. Only 30% ever make it to the next Phase if ever making it to market...
https://www.fda.gov/ForPatients/Approvals/Drugs/ucm405622.htm
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM